Clinical trial

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

NCT01818856

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-12-01

PhasePHASE1

Study timeline

Study start (unknown)2012-12-01Date precision: month

Registry last updated2013-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hepatitis C, Chronicunresolved

HIV Infectionunresolved

Interventions

Ritonavir withdrawal, atazanavir 200 mg/12hDRUG

Telaprevir interactionsDRUG

Sponsors & collaborators

Hospitales Universitarios Virgen del Rocíolead sponsor

Bristol-Myers Squibbcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01818856 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.